122 related articles for article (PubMed ID: 30845292)
1. Immunoexpression of p53 and COX-2 in basal cell carcinoma.
Enache AO; Stepan AE; Mărgăritescu C; Pătraşcu V; Ciurea RN; Simionescu CE; Camen A
Rom J Morphol Embryol; 2018; 59(4):1115-1120. PubMed ID: 30845292
[TBL] [Abstract][Full Text] [Related]
2. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
Bartoš V
Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors.
Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR
J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663
[TBL] [Abstract][Full Text] [Related]
4. p53 protein in aggressive and non-aggressive basal cell carcinoma.
De Rosa G; Staibano S; Barra E; Donofrio V; Salvatore G; Vessecchia G; Boscaino A
J Cutan Pathol; 1993 Oct; 20(5):429-34. PubMed ID: 7507946
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
Bartoš V; Kullová M
Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
[TBL] [Abstract][Full Text] [Related]
7. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
Mateoiu C; Pirici A; Bogdan F
Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53, D2-40 and α-smooth muscle actin in different histological subtypes of facial basal cell carcinoma.
Mercut R; Ciurea ME; Mărgăritescu C; Popescu SM; Crăitoiu MM; Cotoi OS; Voinescu DC
Rom J Morphol Embryol; 2014; 55(2):263-72. PubMed ID: 24969973
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
[TBL] [Abstract][Full Text] [Related]
11. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
[TBL] [Abstract][Full Text] [Related]
12. Comparison of PTCH1, COX-2, p53, and Ki-67 protein expression in basal cell carcinomas of nodular and superficial subtypes arising on the head and trunk.
Khalesi M; Waterhouse M; Whiteman DC; Johns R; Rosendahl C; Hackett T; Pollak T; Kimlin MG; Hacker E; Neale RE;
Int J Dermatol; 2016 Oct; 55(10):1096-105. PubMed ID: 27126210
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
14. Expressions of p53, cyclinD1 and histopathological features in basal cell carcinomas.
Koseoglu RD; Sezer E; Eyibilen A; Aladag I; Etikan I
J Cutan Pathol; 2009 Sep; 36(9):958-65. PubMed ID: 19187116
[TBL] [Abstract][Full Text] [Related]
15. Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin.
Bartoš V; Kullová M
Acta Medica (Hradec Kralove); 2017; 60(1):32-36. PubMed ID: 28591550
[TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
Bartoš V; Kullová M
Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
[TBL] [Abstract][Full Text] [Related]
17. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
18. Correlation and expression of COX-2 and P53 protein in basal cell carcinoma of eyelid.
Chen Z; Yang J; Huang Q
J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):383-6. PubMed ID: 19513627
[TBL] [Abstract][Full Text] [Related]
19. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
20. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
Karagece Yalçin U; Seçkın S
Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
